1. Home
  2. Analysis
  3. Meloxicam
  4. Vyepti

Meloxicam and Vyepti drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Meloxicam (meloxicam) and Vyepti (eptinezumab-jjmr). Common drug interactions include migraine among females and drug ineffective among males.

The phase IV clinical study analyzes what interactions people have when they take Meloxicam and Vyepti. It is created by eHealthMe based on reports of 15 people who take the same drugs from the FDA, and is updated regularly.

What is Meloxicam?

Meloxicam has active ingredients of meloxicam. It is often used in arthritis. eHealthMe is studying from 68,017 Meloxicam users. Check the latest studies of Meloxicam.

What is Vyepti?

Vyepti has active ingredients of eptinezumab-jjmr. eHealthMe is studying from 4,897 Vyepti users. Check the latest studies of Vyepti.

On Aug, 11, 2026

15 people who take Meloxicam and Vyepti together, and have interactions are studied.

Meloxicam and Vyepti drug interactions.

What are the common drug interactions of Meloxicam and Vyepti, by gender? *:

female:

  1. Migraine (headache)
  2. Dizziness
  3. Drug abuse
  4. Eye pruritus (eye itching)
  5. Fatigue (feeling of tiredness)
  6. Influenza like illness
  7. Knee arthroplasty
  8. Pancreatic mass
  9. Psychiatric symptom
  10. Pulmonary mass

male:

  1. Drug ineffective

What are the common drug interactions of Meloxicam and Vyepti, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Dizziness

30-39:

  1. Disturbance in attention
  2. Headache (pain in head)
  3. Joint swelling
  4. Migraine (headache)
  5. Oedema peripheral (superficial swelling)
  6. Photosensitivity reaction
  7. Eye pruritus (eye itching)
  8. Rhinitis (a medical term for irritation and inflammation of the mucous membrane inside the nose)

40-49:

  1. Carpal tunnel decompression
  2. Drug ineffective

50-59:

  1. Psychiatric symptom
  2. Pulmonary mass
  3. Suicide attempt
  4. Migraine (headache)
  5. Drug abuse
  6. Drug ineffective
  7. Fatigue (feeling of tiredness)
  8. Influenza like illness
  9. Pancreatic mass

60+:

  1. Drug ineffective
  2. Migraine (headache)
  3. Therapeutic response decreased (less preventive response)
  4. Knee arthroplasty

What are the existing conditions these people have? *

  1. Migraine (headache): 13 people, 86.67%
  2. Migraine Without Aura (headache without neurological problems): 2 people, 13.33%
  3. Headache (pain in head): 2 people, 13.33%
  4. Wheezing (a high-pitched whistling sound made while you breath): 1 person, 6.67%
  5. Stress And Anxiety: 1 person, 6.67%
  6. Status Migrainosus (a migraine headache for 72 hours): 1 person, 6.67%
  7. Nausea And Vomiting: 1 person, 6.67%
  8. Nausea (feeling of having an urge to vomit): 1 person, 6.67%
  9. Nasal Congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels): 1 person, 6.67%
  10. Hypersensitivity: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Meloxicam and Vyepti?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Meloxicam and Vyepti:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Meloxicam:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Vyepti:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Meloxicam and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Vyepti and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on meloxicam and eptinezumab-jjmr (the active ingredients of Meloxicam and Vyepti, respectively), and Meloxicam and Vyepti (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.